| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.69B | 32.67B | 28.26B | 27.56B | 21.17B | 18.61B |
| Gross Profit | 17.72B | 17.26B | 14.08B | 13.84B | 10.47B | 9.65B |
| EBITDA | 12.80B | 12.43B | 10.18B | 10.02B | 7.16B | 7.21B |
| Net Income | 10.01B | 9.61B | 7.57B | 7.84B | 5.62B | 5.88B |
Balance Sheet | ||||||
| Total Assets | 48.06B | 50.57B | 48.59B | 39.96B | 36.30B | 30.23B |
| Cash, Cash Equivalents and Short-Term Investments | 8.38B | 13.32B | 12.74B | 7.01B | 7.38B | 7.59B |
| Total Debt | 2.71B | 2.71B | 4.69B | 4.63B | 4.26B | 4.58B |
| Total Liabilities | 27.23B | 30.95B | 30.11B | 26.51B | 27.49B | 20.09B |
| Stockholders Equity | 20.83B | 19.61B | 18.48B | 13.45B | 8.81B | 10.14B |
Cash Flow | ||||||
| Free Cash Flow | 8.96B | 11.08B | 9.08B | 3.25B | 7.22B | 9.91B |
| Operating Cash Flow | 11.13B | 12.66B | 11.17B | 5.44B | 8.49B | 10.85B |
| Investing Cash Flow | -4.41B | -3.78B | -2.61B | -2.69B | -1.03B | -72.00M |
| Financing Cash Flow | -7.83B | -8.67B | -2.83B | -3.00B | -7.14B | -9.89B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | €463.19B | 39.12 | 52.14% | 0.73% | 9.70% | 16.89% | |
77 Outperform | €40.71B | 32.64 | 19.21% | 0.58% | 2.03% | 105.75% | |
68 Neutral | €20.02B | 68.74 | 35.84% | 1.65% | 4.42% | -15.18% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |